We are live on
!
Find out more
KC
Kryger Capital Portfolio holdings
AUM
$1.41B
1-Year Est. Return
86.31%
This Fund
S&P 500
This Quarter
Est. Return
+27.79%
1 Year Est. Return
+86.31%
3 Year Est. Return
+420.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.29B
AUM Growth
+$429M
(+50%)
Cap. Flow
+$323M
Cap. Flow
% of AUM
24.93%
Top 10 Holdings %
Top 10 Hldgs %
68.2%
Holding
65
New
33
Increased
16
Reduced
1
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CFLT
Confluent
CFLT
|
+$92.1M |
| 2 |
EXAS
Exact Sciences
EXAS
|
+$81.1M |
| 3 |
DAY
Dayforce
DAY
|
+$77.5M |
| 4 |
RNAM
Avidity Biosciences
RNAM
|
+$67.5M |
| 5 |
Electronic Arts
EA
|
+$61.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRNA
Verona Pharma
VRNA
|
+$103M |
| 2 |
MRUS
Merus
MRUS
|
+$99.2M |
| 3 |
COOP
Mr. Cooper
COOP
|
+$85.8M |
| 4 |
MTAL
Metals Acquisition
MTAL
|
+$44.7M |
| 5 |
INFA
Informatica
INFA
|
+$40.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.17% |
| 2 | Healthcare | 25.42% |
| 3 | Industrials | 19.93% |
| 4 | Communication Services | 12.65% |
| 5 | Financials | 7.6% |
Similar funds
EWS
CBA
SCM
PTC
QC
BC
KCM
EA
Kryger Capital's Q4 2025 Portfolio in Review
As of Q4 2025, Kryger Capital held 65 positions worth $1.29B, up 50% from $866M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Kryger Capital deployed $323M of net new capital in Q4 2025, opening 33 new positions and adding to 16 existing holdings. Its largest new stake was Confluent: 3,750,000 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Riot Platforms, an estimated $2.21M trimmed.
- Kryger Capital's largest Q4 2025 buy was Confluent: 3,750,000 shares worth $113M.
- Kryger Capital added most to Norfolk Southern in Q4 2025, an estimated $46.9M increase.
- Kryger Capital's biggest Q4 2025 reduction was Riot Platforms, cutting an estimated $2.21M.
- Kryger Capital fully exited Verona Pharma in Q4 2025, selling an estimated $103M.
- Kryger Capital's ten largest holdings make up 68% of its $1.29B portfolio in Q4 2025.
- Kryger Capital opened 33 new positions and closed 15 in Q4 2025.
- Kryger Capital's portfolio value rose 50% quarter-over-quarter to $1.29B.
Based on Kryger Capital's 13F filing for Q4 2025, filed 17 Feb 2026.